Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shomik Sengupta

Showing results (131-140 of 166) with videos related to

Pageof 17
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 24, 2017
Prostate cancer post-prostatectomy radiotherapy: CT vs MRI for vesico-urethral anastomosis target delineationDaryl Lim Joon, Adeline Lim, Michal Schneider, et al.
Cancer|December 15, 2005
The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinomaShomik Sengupta, Christine M Lohse, John C Cheville, et al.
Cancer|June 24, 2005
Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressivenessShomik Sengupta, Christine M Lohse, Bradley C Leibovich, et al.
Urology|October 1, 2005
B7-H1 glycoprotein blockade: a novel strategy to enhance immunotherapy in patients with renal cell carcinomaR Houston Thompson, W Scott Webster, John C Cheville, et al.
BJUI Compass|September 17, 2025
Perioperative chemotherapy use and related outcomes in muscle-invasive bladder cancer in AustraliaAlison Hiong, James Lynam, Andrew Weickhardt, et al.
BJU International|August 22, 2025
Treatment variations in localised prostate cancer in Australia and New Zealand: a registry studyKaren Chiam, Albert Bang, Visalini Nair-Shalliker, et al.
Kidney Cancer (Clifton, Va.)|February 12, 2019
What Survival Benefits are Needed to Make Adjuvant Sorafenib Worthwhile After Resection of Intermediate- or High-Risk Renal Cell Carcinoma? Clinical Investigators' Preferences in the SORCE TrialNicola J Lawrence, Andrew Martin, Ian D Davis, et al.
BJU International|September 4, 2015
The role of cystectomy in elderly patients - a multicentre analysisLaura Izquierdo, Lluis Peri, Priscila Leon, et al.
World Journal of Urology|October 6, 2018
Fiducial markers: can the urologist do better?Catriona Duncan, Daryl Lim Joon, Nathan Lawrentschuk, et al.
Cancer|May 19, 2006
Mononuclear cell infiltration in clear-cell renal cell carcinoma independently predicts patient survivalW Scott Webster, Christine M Lohse, R Houston Thompson, et al.
Pageof 17

Showing results (131-140 of 166) with videos related to

Sort By:
Pageof 17
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 24, 2017
Prostate cancer post-prostatectomy radiotherapy: CT vs MRI for vesico-urethral anastomosis target delineationDaryl Lim Joon, Adeline Lim, Michal Schneider, et al.
Cancer|December 15, 2005
The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinomaShomik Sengupta, Christine M Lohse, John C Cheville, et al.
Cancer|June 24, 2005
Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressivenessShomik Sengupta, Christine M Lohse, Bradley C Leibovich, et al.
Urology|October 1, 2005
B7-H1 glycoprotein blockade: a novel strategy to enhance immunotherapy in patients with renal cell carcinomaR Houston Thompson, W Scott Webster, John C Cheville, et al.
BJUI Compass|September 17, 2025
Perioperative chemotherapy use and related outcomes in muscle-invasive bladder cancer in AustraliaAlison Hiong, James Lynam, Andrew Weickhardt, et al.
BJU International|August 22, 2025
Treatment variations in localised prostate cancer in Australia and New Zealand: a registry studyKaren Chiam, Albert Bang, Visalini Nair-Shalliker, et al.
Kidney Cancer (Clifton, Va.)|February 12, 2019
What Survival Benefits are Needed to Make Adjuvant Sorafenib Worthwhile After Resection of Intermediate- or High-Risk Renal Cell Carcinoma? Clinical Investigators' Preferences in the SORCE TrialNicola J Lawrence, Andrew Martin, Ian D Davis, et al.
BJU International|September 4, 2015
The role of cystectomy in elderly patients - a multicentre analysisLaura Izquierdo, Lluis Peri, Priscila Leon, et al.
World Journal of Urology|October 6, 2018
Fiducial markers: can the urologist do better?Catriona Duncan, Daryl Lim Joon, Nathan Lawrentschuk, et al.
Cancer|May 19, 2006
Mononuclear cell infiltration in clear-cell renal cell carcinoma independently predicts patient survivalW Scott Webster, Christine M Lohse, R Houston Thompson, et al.
Pageof 17